Malignant melanoma: REPORT OF A MEETING OF PHYSICIANS AND SCIENTISTS, UNIVERSITY COLLEGE LONDON MEDICAL SCHOOL
- 17 October 1992
- journal article
- grand round
- Published by Elsevier in The Lancet
- Vol. 340 (8825) , 948-951
- https://doi.org/10.1016/0140-6736(92)92825-z
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Treatment of Metastatic Malignant Melanoma with Dacarbazine plus TamoxifenNew England Journal of Medicine, 1992
- Cutaneous malignant melanoma, Scotland, 1979-89The Lancet, 1992
- Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole: a phase III study by the National Cancer Institute of Canada Clinical Trials Group.Journal of Clinical Oncology, 1991
- A phase II study of taxol in patients with malignant melanomaInvestigational New Drugs, 1991
- Final report of the french multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastasesCancer, 1990
- The importance of tamoxifen to a cisplatin-containing regimen in the treatment of metastatic melanomaCancer, 1989
- The role of regional hyperthermic cytostatic perfusion in the treatment of extremity melanomaCancer, 1988
- The role of radiotherapy in recurrent and metastatic malignant melanoma: a clinical radiobiological studyInternational Journal of Radiation Oncology*Biology*Physics, 1986
- A Comparison of Prognostic Factors and Surgical Results in 1,786 Patients with Localized (Stage I) Melanoma Treated in Alabama, USA, and New South Wales, AustraliaAnnals of Surgery, 1982
- Adjuvant Immunotherapy with BCG in Treatment of Regional-Lymph-Node Metastases from Malignant MelanomaNew England Journal of Medicine, 1976